Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized study of adalimumab versus placebo in Dupuytren contracture undergoing fasciotomy
2023-503701-11-00Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in Dupuytren's contracture comparing Adalimumab arm with Placebo (saline) arm (2 arms). Primary endpoint: Finger extension improvement. Started Jul 2023; status: completed.
02
Drugs
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2023-503701-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503701-11-00.